The Spectranetics Corporation Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	42
ISBN Number	not applicable
Product Code	GMD04646

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a The Spectranetics Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook Cardiovascular Devices
3 Major Products and Services
3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
6.1 Head Office
6.2 Other Locations & Subsidiaries
7 Recent Developments
7.1 Financial Announcements
- 7.1.1 Jul 29, 2008: Spectranetics Reports 2Q 2008 Results
- 7.1.2 Apr 23, 2008: Spectranetics Declares Q1 2008 Results
- 7.1.3 Apr 15, 2008: Spectranetics To Declare Q1 2008 Results
- 7.1.4 Feb 20, 2008: Spectranetics Reports Q4 2007 Results
- 7.1.5 Oct 31, 2007: Spectranetics Reports Q3 2007 Results
- 7.1.6 Jul 25, 2007: Spectranetics Reports Q2 2007 Results
- 7.1.7 Apr 19, 2007: Spectranetics Reports Q1 2007 Results
- 7.1.8 Feb 22, 2007: Spectranetics Reports Q4 2006 Results
7.2 Corporate Communications
- 7.2.1 Aug 13, 2008: Spectranetics Announces Management changes At vascular Unit
- 7.2.2 Jul 07, 2008: Spectranetics Appoints Vice President And General Manager Of Vascular Intervention Business
- 7.2.3 Feb 14, 2008: Spectranetics Appoints New VP, Clinical Affairs
- 7.2.4 Feb 14, 2008: Spectranetics Appoints VP, Clinical Affairs
- 7.2.5 Jun 07, 2007: Spectranetics Director Retires
- 7.2.6 Jun 07, 2007: Spectranetics Appoints VP, Quality Assurance and Regulatory Compliance
- 7.2.7 Apr 05, 2007: Spectranetics Appoints Managing Director For European Operations
- 7.2.8 Feb 22, 2006: Spectranetics Appoints VP, US Sales
7.3 Legal and Regulatory
- 7.3.1 Apr 08, 2008: Medtronic Settles Lawsuit With Spectranetics
7.4 Product News
- 7.4.1 Jun 05, 2008: Spectranetics Enrolls First Patients In TAAMI Trial
- 7.4.2 May 12, 2008: Spectranetics Laser System Successfully Assists Removal Of 975 Cardiac Leads
- 7.4.3 Feb 25, 2008: First Patient Enrolled In Study Evaluating Performance Of Spectranetics Laser Ablation
- 7.4.4 Jul 29, 1997: Spectranetics Laser Sheath For Removing Pacemaker Leads Unanimously Recommended By Fda Advisory Committee
7.5 Clinical Trials
- 7.5.1 Jun 05, 2008: Spectranetics Enrolls First Patients In TAAMI Trial
- 7.5.2 May 12, 2008: Spectranetics Laser System Successfully Assists Removal Of 975 Cardiac Leads
- 7.5.3 Feb 25, 2008: First Patient Enrolled In Study Evaluating Performance Of Spectranetics Laser Ablation
8 The Spectranetics Corporation Pipeline Products
8.1 The Spectranetics Corporation Product Pipeline Analysis
- 8.1.1 The Spectranetics Corporation Pipeline Products By Equipment Type
- 8.1.2 The Spectranetics Corporation Pipeline Products By Development Stage
- 8.1.3 The Spectranetics Corporation Pipeline Products By Therapy Area
- 8.1.4 The Spectranetics Corporation Pipeline Products By Clinical Trials
- 8.1.5 The Spectranetics Corporation Pipeline Products By News Summary
8.2 Spectranetics Laser Sheath (SLS II)
- 8.2.1 Product Description
- 8.2.2 Product Status
- 8.2.3 Clinical Trials
- 8.2.4 Product Milestone
8.3 Lead Locking Device
- 8.3.1 Product Description
- 8.3.2 Product Status
- 8.3.3 Product Patent Details
8.4 CLiRpath Turbo excimer laser catheter
- 8.4.1 Product Description
- 8.4.2 Product Status
- 8.4.3 Clinical Trials
9 Appendix
9.1 Methodology
- 9.1.1 Coverage
- 9.1.2 Secondary Research
- 9.1.3 Primary Research
- 9.1.4 Expert Panel Validation
9.2 Contact Us
9.3 About Global Markets Direct
9.4 Disclaimer
1.1 List Of Tables
Table 1: The Spectranetics Corporation,Key Facts
Table 2: The Spectranetics Corporation, Key Employees,
Table 3: The Spectranetics Corporation, Other Locations
Table 4: The Spectranetics Corporation Pipeline Products by Equipment Type
Table 5: The Spectranetics Corporation Pipeline Products By Development Stage
Table 6: The Spectranetics Corporation Pipeline Products By Therapy Area
Table 7: The Spectranetics Corporation Pipeline Products By Clinical Trials
Table 8: The Spectranetics Corporation Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: The Spectranetics Corporation Pipeline Products By Development Stage
Figure 2: Global Markets Direct Methodology